ALK

ALK is a world leader in allergy immunotherapy – a treatment of the underlying cause of allergy

  • ALK divested the largest European veterinary allergy business
  • Flemming Pedersen, CFO of ALK stated: “Kempen & Co has done a great job in selling our European veterinary business in a smooth process, dedicatedly run and most important with a selling price well above expectations. We would definitely appoint them again.”
  • Kempen & Co acted as exclusive M&A adviser to the seller
Disclaimer Kempen Privacy statement Kempen Disclaimer Kempen & Co Privacy statement Kempen & Co Statement under the UK Modern Slavery Act Cookie Settings
Kempen & Co is a trade name of Van Lanschot Kempen Wealth Management NV. Both Van Lanschot Kempen Wealth Management NV and Kempen Capital Management NV are part of Van Lanschot Kempen NV